Michael D. Leise
Mayo Clinic(US)Mayo Clinic in Arizona(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Hepatitis C virus research, Organ Transplantation Techniques and Outcomes, Hepatitis B Virus Studies
Most-Cited Works
- → Drug-Induced Liver Injury(2014)404 cited
- → Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk(2015)198 cited
- → Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma(2019)187 cited
- → Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant(2015)180 cited
- → A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation(2011)167 cited
- → Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study(2019)161 cited
- → Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States(2016)150 cited
- → Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma(2016)134 cited
- → Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding(2018)123 cited
- → Management of Hepatic Encephalopathy in the Hospital(2014)104 cited